Publications by authors named "U Jaeger"

Claim this Profile
P
Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe.
Elise R A Pennings, Anne M Spanjaart, Frederick W Thielen, Simone Oerlemans, Anna Fleischer, Ulrich Jaeger

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First impressions count: Therapists' impression on patients' motivation and helping alliance predicts psychotherapy dropout.
Kristin Jankowsky, Johannes Zimmermann, Ulrich Jaeger, Robert Mestel, Ulrich Schroeders

Psychother Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of in vivo CAR transgene levels in tisagenlecleucel-treated patients with relapsed/refractory B-ALL and DLBCL.
Rakesh Awasthi, Stephan A Grupp, Edward R Waldron, Gregory A Yanik, Constantine S Tam, Ulrich Jaeger

Blood Adv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The MURANO study: final analysis and retreatment/crossover substudy results of VenR for patients with relapsed/refractory CLL.
Arnon P Kater, Rosemary Harrup, Thomas J Kipps, Barbara Eichhorst, Carolyn J Owen, Ulrich Jaeger

Blood· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term immune changes in patients with relapsed/refractory chronic lymphocytic leukemia following treatment with venetoclax plus rituximab.
Arnon P Kater, Barbara F Eichhorst, Carolyn J Owen, Ulrich Jaeger, Brenda Chyla

Hemasphere· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis